INR Magazine

Literary contributors for past issues:

Dr. Jack Ansell M.D. Jack E. Ansell, M.D. is Professor of Medicine at Boston University School of Medicine and Vice Chairman for Clinical Affairs, Department of Medicine, at Boston University Medical Center. Dr. Ansell' s research has focused on the disciplines of Hemostasis and Thrombosis, especially in the areas of Thrombotic Disorders and Antithrombotic Therapy. He has had a continued interest and involvement in the application of new modes of delivering and monitoring anticoagulants, and particularly in the management of oral anticoagulant therapy. He has published extensively and lectured widely on these topics.

Henry I. Bussey, Pharm.D, FCCP, FAHA College of Pharmacy, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. Henry I. Bussey is primarily interested in applied clinical research dealing with cardiovascular therapeutics and anticoagulants. He has participated as a principal investigator and co-investigator in a number of trials dealing with new pharmacologic agents in the management of hypertension, congestive heart failure, and angina.

American Heart Association Darlene Hawkes Yblood, Sr. Communications Manager at the National Center of the American Heart Association has offered comprehensive literary content for INR Magazine. To be included in the fall issue is their newest program entitled "Failure is not an Option". This program addresses heart failure in Americans and discusses prevention and treatments.

Included are additional authors and experts in the fields of anticoagulation, fitness, diet and insurance.

..................................................... .............wayne@inrmagazine.com
Home ............About INR Magazine ..... ......................Request Information .......................... Subscribe .................................. Advertise
Literary contributors for past issues: Dr. Jack Ansell M.D. Jack E. Ansell, M.D. is Professor of Medicine at Boston University School of Medicine and Vice Chairman for Clinical Affairs, Department of Medicine, at Boston University Medical Center. Dr. Ansell' s research has focused on the disciplines of Hemostasis and Thrombosis, especially in the areas of Thrombotic Disorders and Antithrombotic Therapy. He has had a continued interest and involvement in the application of new modes of delivering and monitoring anticoagulants, and particularly in the management of oral anticoagulant therapy. He has published extensively and lectured widely on these topics. Henry I. Bussey, Pharm.D, FCCP, FAHA College of Pharmacy, The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. Henry I. Bussey is primarily interested in applied clinical research dealing with cardiovascular therapeutics and anticoagulants. He has participated as a principal investigator and co-investigator in a number of trials dealing with new pharmacologic agents in the management of hypertension, congestive heart failure, and angina. American Heart Association Darlene Hawkes Yblood, Sr. Communications Manager at the National Center of the American Heart Association has offered comprehensive literary content for INR Magazine. To be included in the fall issue is their newest program entitled "Failure is not an Option". This program addresses heart failure in Americans and discusses prevention and treatments. Included are additional authors and experts in the fields of anticoagulation, fitness, diet and insurance.			INR Magazine Vitals: Size: 48 pages, 8.5 X 11 Type: Full color Demographic: INR patients, families, clinicians and their physicians. Distribution: 11,000 per issue Available to 1,400+ warfarin clinics nationwide. Provided to patients free of charge. 24k Cardiology offices and thoracic surgeons nation wide Spring 2011 Issue scheduled for release in May. Contact us Focus: Patient information, education and participation in personal warfarin therapy management. INR related subjects that include: INR management and intervention, self-testing monitors and supplies, Medicare and private insurance reimbursement, clotting, DVT, general health, vitamin K nutrition, exercise and other topics of interest for INR patients and their families. Rates and Considerations: INR magazine is committed to its content, in both quality and quantity. In view of these priorities, INR magazine will significantly limit the amount of advertising in each issue. This will serve to highlight the included advertisers and provide the additional literary space for vital educational and informational concerns. Full page color ad: $ 5,500 Back cover: $12,000 Inside front cover: $ 8,000 Inside back cover: $ 7,000